Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CC Stock Forecast 2025-2026
$11.00
Current Price
$1.65B
Market Cap
Buy 4
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to CC Price Targets
+81.8%
To High Target of $20.00
+27.3%
To Median Target of $14.00
0.0%
To Low Target of $11.00
CC Price Momentum
+0.2%
1 Week Change
-1.5%
1 Month Change
-52.2%
1 Year Change
-34.9%
Year-to-Date Change
-56.9%
From 52W High of $25.54
+20.5%
From 52W Low of $9.13
📊 TOP ANALYST CALLS
Did CC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Chemours is one of their latest high-conviction picks.
Latest CC Stock Price Targets & Analyst Predictions
Based on our analysis of 16 Wall Street analysts, CC has a neutral consensus with a median price target of $14.00 (ranging from $11.00 to $20.00). The overall analyst rating is Buy (7.8/10). Currently trading at $11.00, the median forecast implies a 27.3% upside. This outlook is supported by 4 Buy, 4 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Richard Wolfe at CFRA, suggesting a 0.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CC Analyst Ratings
4
Buy
4
Hold
0
Sell
CC Price Target Range
Low
$11.00
Average
$14.00
High
$20.00
Current: $11.00
Latest CC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 28, 2025 | Barclays | Michael Leithead | Equal-Weight | Maintains | $13.00 |
| May 14, 2025 | Goldman Sachs | Duffy Fischer | Neutral | Maintains | $14.00 |
| May 12, 2025 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $15.00 |
| May 8, 2025 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $14.00 |
| May 7, 2025 | UBS | Joshua Spector | Buy | Maintains | $17.00 |
| Apr 14, 2025 | Truist Securities | Peter Osterland | Buy | Maintains | $22.00 |
| Apr 1, 2025 | Barclays | Michael Leithead | Equal-Weight | Maintains | $16.00 |
| Mar 27, 2025 | Mizuho | John Roberts | Outperform | Upgrade | $19.00 |
| Feb 24, 2025 | Barclays | Michael Leithead | Equal-Weight | Maintains | $19.00 |
| Feb 19, 2025 | BMO Capital | John McNulty | Outperform | Maintains | $27.00 |
| Jan 28, 2025 | Truist Securities | Peter Osterland | Buy | Initiates | $27.00 |
| Jan 13, 2025 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $22.00 |
| Jan 7, 2025 | Goldman Sachs | Duffy Fischer | Neutral | Maintains | $21.00 |
| Jan 7, 2025 | Mizuho | John Roberts | Neutral | Maintains | $21.00 |
| Dec 12, 2024 | RBC Capital | Arun Viswanathan | Outperform | Reiterates | $25.00 |
| Nov 6, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $25.00 |
| Nov 5, 2024 | Barclays | Michael Leithead | Equal-Weight | Maintains | $23.00 |
| Nov 5, 2024 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $25.00 |
| Oct 11, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $28.00 |
| Oct 7, 2024 | BMO Capital | John McNulty | Outperform | Maintains | $32.00 |
Chemours Co. (CC) Competitors
The following stocks are similar to Chemours based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Chemours Co. (CC) Financial Data
Chemours Co. has a market capitalization of $1.65B with a P/E ratio of 61.1x. The company generates $5.79B in trailing twelve-month revenue with a 0.5% profit margin.
Revenue growth is +0.4% quarter-over-quarter, while maintaining an operating margin of +6.4% and return on equity of +4.2%.
Valuation Metrics
Market Cap
$1.65B
Enterprise Value
$5.56B
P/E Ratio
61.1x
PEG Ratio
4.8x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+0.4%
Gross Margin
+17.3%
Operating Margin
+6.4%
Net Margin
+0.5%
EPS Growth
+1.3%
Financial Health
Cash/Price Ratio
+28.2%
Current Ratio
1.8x
Debt/Equity
755.3x
ROE
+4.2%
ROA
+3.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Chemours Co. (CC) Business Model
About Chemours Co.
What They Do
Global provider of performance chemicals.
Business Model
The company generates revenue by manufacturing and selling a diverse range of chemical products, including titanium technologies and fluoroproducts, which are essential for various industries such as automotive, electronics, and energy. Chemours focuses on innovation and sustainability, ensuring that its products meet market demands while adhering to environmental standards.
Additional Information
Headquartered in Wilmington, Delaware, Chemours has a significant global presence and is dedicated to advancing chemistry and innovation. Its products are critical for high-performance applications, enhancing the durability and aesthetic qualities of finished goods.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
6,000
CEO
Ms. Denise M. Dignam
Country
United States
IPO Year
2015
Website
www.chemours.comChemours Co. (CC) Latest News & Analysis
Latest News
Quick Summary
Chemours Company ($CC) has released an update regarding its outlook for the second quarter of 2025. Further details can be found in their official communications.
Why It Matters
The Chemours Company's Q2 2025 outlook update can influence stock performance, guiding investor expectations regarding revenue, profitability, and market conditions.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The chemicals company anticipates sales growth in the low to mid-teens sequentially and expects adjusted EBITDA to rise by 40% to 45%.
Why It Matters
Strong sales and earnings growth forecasts indicate robust company performance, potentially leading to higher stock valuations and increased investor confidence.
Source: Market Watch
Market Sentiment:
Positive
Quick Summary
Chemours has appointed Matthew Conti as Chief Human Resources Officer.
Why It Matters
Leadership changes can impact a company's strategy and culture, potentially affecting employee morale and productivity, which in turn influences financial performance and stock value.
Source: Business Wire
Market Sentiment:
Neutral
Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio
10 days ago
Quick Summary
Chemours has appointed Nathan Blom as Vice President of its Liquid Cooling Growth Portfolio, focusing on technology and data center infrastructure.
Why It Matters
Chemours appointing Nathan Blom signals a strategic focus on the liquid cooling market, potentially enhancing innovation and competitive positioning, which may impact future growth and profitability.
Source: Business Wire
Market Sentiment:
Neutral
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
23 days ago
Quick Summary
Investors often seek dividend-yielding stocks during market turbulence, as these companies typically have strong cash flows and provide high dividend payouts.
Why It Matters
Dividend-yielding stocks attract investors during market turbulence, reflecting a preference for stability and income, often signaling strong cash flow and financial health in uncertain times.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
CC's new deal will enhance data center efficiency through advanced cooling techniques, including two-phase direct-to-chip and immersion cooling methods.
Why It Matters
The deal signals CC's commitment to innovation in data center efficiency, potentially reducing operational costs and increasing competitiveness, which can positively impact its stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About CC Stock
What is Chemours Co.'s (CC) stock forecast for 2025?
Based on our analysis of 16 Wall Street analysts, Chemours Co. (CC) has a median price target of $14.00. The highest price target is $20.00 and the lowest is $11.00.
Is CC stock a good investment in 2025?
According to current analyst ratings, CC has 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $11.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CC stock?
Wall Street analysts predict CC stock could reach $14.00 in the next 12 months. This represents a 27.3% increase from the current price of $11.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Chemours Co.'s business model?
The company generates revenue by manufacturing and selling a diverse range of chemical products, including titanium technologies and fluoroproducts, which are essential for various industries such as automotive, electronics, and energy. Chemours focuses on innovation and sustainability, ensuring that its products meet market demands while adhering to environmental standards.
What is the highest forecasted price for CC Chemours Co.?
The highest price target for CC is $20.00 from at , which represents a 81.8% increase from the current price of $11.00.
What is the lowest forecasted price for CC Chemours Co.?
The lowest price target for CC is $11.00 from Richard Wolfe at CFRA, which represents a 0.0% decrease from the current price of $11.00.
What is the overall CC consensus from analysts for Chemours Co.?
The overall analyst consensus for CC is neutral. Out of 16 Wall Street analysts, 4 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $14.00.
How accurate are CC stock price projections?
Stock price projections, including those for Chemours Co., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 20, 2025 2:32 AM UTC